First-in-Class Drug Brings Relief in Ulcerative Colitis

(MedPage Today) -- A first-in-class investigational agent offered symptom relief to patients with active moderate-to-severe ulcerative colitis (UC), according to a phase IIb randomized trial.
Among over 200 patients, those who received three different...